Developmental Toxicology Studies of WHI-07,a Novel Nucleoside Analogue-Based Dual-Function Microbicide,Administered Intravaginally to Rabbits

Abstract

The zidovudine derivative, 5-bromo-6-methoxy-5,6-dihydro-3-azidothymidine-5'-(p-bromophenyl) methoxy alaninyl phosphate (WHI-07), is a dual-function spermicidal and anti-HIV agent with contraceptive and microbicidal activity. In previous subchronic and reproductive toxicity studies and a two-year carcinogenicity study, daily intravaginal application of 0.5 to 2.0% WHI-07 via a gel-microemulsion, was shown to cause no local, systemic and reproductive toxicity or increased carcinogenicity in mice. To evaluate the developmental toxicity potential of WHI-07 in a nonrodent model, subgroups of 20 superovulated NZW rabbits were artificially inseminated and exposed intravaginally to a gel-microemulsion containing 0, 0.5, 1.0, or 2.0% WHI-07 during major organogenesis [gestation days 6—18]. The dose of WHI-07 was equivalent to 1.4 × 106 to 5.7 × 106 times its anti-HIV IC50 and 1400 to 5700 times its spermicidal EC50. Throughout the duration of the experiment (GD 0-29), clinical observations, food consumption, and body weights were recorded. Reproductive and fetal parameters were evaluated following uterotomies on GD 29. Measurements included numbers of corpora lutea, pregnancy, number and distribution of implantations, resorptions, live and dead fetuses, fetal weight, sex ratio, and gross external and skeletal malformations and variations. Maternal food consumption and body weight gain were unaffected by WHI-07 treatment. Hematologic and clinical chemistry determinations on GD 19 and 29 revealed no treatment-related maternal effects. Prior studies of repeated intravaginal administration of WHI-07 gel-microemulsion revealed lack of local toxicity to rabbit vaginal mucosa. In the current study, no drug-related gross lesions were apparent at necropsy. Reproductive indices, ie, pregnancy rate, gravid uterine weights, litter size, number of corpora lutea, implantation sites, pre- and postimplantation losses, viable fetuses, resorptions, fetal body weights, and fetal sex ratio, were not affected by intravaginal exposure to WHI-07. External, and skeletal examinations of fetuses for malformations and variations did not reveal any evidence of teratogenicity in any WHI-07-treated groups. Intravaginal administration of WHI-07 at concentrations as high as 2% did not produce teratogenicity or other developmental toxicity in rabbit conceptus. These findings indicated that WHI-07 shows unique clinical potential to become the active ingredient of a new female-controlled topical microbicidal vaginal contraceptive for women who are at high risk of acquiring HIV/AIDS.

Keywords

HIV/AIDS developmental toxicity teratogenicity spermicidal microbicide zidovudine.

References

Ayers KM , Clive D. , Tucker WE Jr , Hajian G. , de Miranda P. (1996). Nonclinical toxicology studies with zidovudine: genetic toxicity tests and carcinogenicity bioassays in mice and rats. Fundam Appl Toxicol 32: 148—158.

Ayers KM , Torrey CE , Reynolds DJ (1997). A transplacental carcinogenicity bioassay in CD-1 mice with zidovudine. Fundam Appl Toxicol 38: 195— 198.

Ayers KM , Tucker WE Jr , Hajian G. , de Miranda P. (1996). Nonclinical toxicology studies with zidovudine: acute, subacute, and chronic toxicity in rodents, dogs, and monkeys. Fundam Appl Toxicol 32: 129—139.

Carneiro M. , Sanchez A. , Maneiro P. , Angelosante W. , Perez C. , Vallee M. (2001). Vertical HIV-1 transmission: prophylaxis and paediatric follow-up. Placenta 22 (Suppl A): S13—18.

Center for Disease Control, Atlanta. Updates on HIV/AIDS, sexually transmitted diseases, and tuberculosis prevention . News Updates, January and May 2002.

D'Cruz OJ , Erbeck D. , Waurzyniak B. , Uckun FM (2002). Two-year toxicity and carcinogenicity studies in B6C3F1 mice with 5-bromo-6-methoxy-5,6-dihydro-3'-azidothymidine-5'-(p-bromophenyl) methoxyalaninyl phosphate (WHI-07), a novel anti-HIV and contraceptive agent . Toxicology 179: 61—77.

D'Cruz OJ , Shih M-L. , Yiv SH , Chen C-L. , Uckun, FM (1999). Synthesis, characterization and preclinical formulation of a novel phenyl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07) with potent anti-HIV and spermicidal activities . Mol Hum Reprod 5: 421—432.

D'Cruz OJ , Uckun FM (2001a). Short-term (13-week) toxicity study of 5-bromo-6-methoxy-5,6-dihydro-3'-azidothymidine-5'-(p-bromophenyl) methoxyalaninyl phosphate (WHI-07), a novel anti-HIV and contraceptive agent, in B6C3F1 mice. Toxicol Sci 60: 373—378.

D'Cruz OJ , Uckun FM (2001b). Lack of adverse effects on fertility of female CD-1 mice exposed to repetitive intravaginal gel-microemulsion formulation of a dual-function anti-HIV agent: aryl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07). J Appl Toxicol 21: 317—322.

10.

D'Cruz OJ , Uckun FM (2001c). Gel-microemulsions as vaginal spermicides and intravaginal drug delivery vehicles. Contraception 64: 113—123.

11.

D'Cruz OJ , Uckun FM (2001d). Intravaginal toxicity studies of a gel-microemulsion formulation of spermicidal vanadocenes in rabbits . Toxicol Appl Pharmacol 170: 104—112.

12.

D'Cruz OJ , Uckun FM (2001e). Effect of pretreatment of semen with poke-weed antiviral protein on pregnancy outcome in the rabbit model. Fertil Steril 76: 830—833.

13.

D'Cruz OJ , Uckun FM (2002). Pre-clinical safety evaluation of novel nucleoside analogue-based dual-function microbicides (WHI-05 and WHI-07). J Antimicrob Chemother 50: 793—803.

14.

D'Cruz OJ , Uckun FM (2003a). Contraceptive activity of a spermicidal aryl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07) in rabbits. Fertil Steril 79: 864—872.

15.

D'Cruz OJ , Uckun FM (2003b). Clinical development of microbicides targeting HIV. Expert Opin Investig Drugs (in press).

16.

D'Cruz OJ , Venkatachalam TK , Uckun FM (2000). Structural requirements for potent human spermicidal activity of dual-function aryl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07). Biol Reprod 62: 37—44.

17.

D'Cruz OJ , Venkatachalam TK , Uckun FM (2001). Thymidine kinase-independent intracellular delivery of bioactive nucleotides by aryl phosphate derivatives of bromo-methoxy zidovudine (compounds WHI-05 and WHI-07) in normal human genital tract epithelial cells and sperm. Biol Reprod 64: 51—59.

18.

D'Cruz OJ , Venkatachalam TK , Zhu Z. , Shih M-L. , Uckun FM (1998). Bromo-methoxy and aryl phosphate derivatives of azidothymidine are dual function spermicides with potent anti-HIV activity. Biol Reprod 59: 503— 515.

19.

D'Cruz OJ , Waurzyniak B. , Yiv SH , Uckun FM (2000). Evaluation of subchronic (13-week) and reproductive toxicity potential of intravaginal gel-microemulsion formulation of a dual-function phenyl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07) in B6C3F1 mice. J Appl Toxicol 20: 319—325.

20.

D'Cruz OJ , Zhu Z. , Yiv SH , Chen CL , Waurzyniak B. , Uckun FM (1999). WHI-05, a novel bromo-methoxy substituted phenyl phosphate derivative of zidovudine, is a dual-action spermicide with potent anti-HIV activity. Contraception 59: 319—331.

21.

de Jong HJ (1999). The safety of pharmaceutical excipients Therapie 54: 11—14.

22.

Eccleston GM (1992). Microemulsion, In: Encyclopedia of Pharmaceutical Technology, Swarbrick J , Boylan JC (eds). Marcel Dekker, New York, pp. 375—421.

23.

Fernandez AD , McNeeley DF (2000). Management of the infant born to a mother infected with human immunodeficiency virus type 1 (HIV-1): current concepts. Am J Perinatol 17: 429—436.

24.

Gayle H. (2000). An overview of the global HIV/AIDS epidemic, with a focus on the United States. AIDS 14 (Suppl 2): S8—S17.

25.

Greene JA , Ayers KM , Tucker WE Jr , de Miranda P. (1996). Nonclinical toxicology studies with zidovudine: reproductive toxicity studies in rats and rabbits. Fundam Appl Toxicol 32: 140—147.

26.

Hader SL , Smith DK , Moore JS , Holmberg SD (2001). HIV infection in women in the United States: status at the Millennium. JAMA 285: 1186— 1192.

27.

Hanson IC , Antonelli TA , Sperling RS , Oleske JM , Cooper E. , Culnane M. , Fowler MG , Kalish LA , Lee SS , McSherry G. , Mofenson L. , Shapiro DE (1999). Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine. J Acquir Immune Defic Syndr Hum Retrovirol 20: 463—467.

28.

Hiv and AIDS—United States, 1981—2000. Morb Mortal Wkly Rep 2001, 50: 430—434.

29.

HIV Infection in Women. National Institute of Allergy and Infectious Diseases Fact Sheet, December 2002.

30.

Jan S-T. , Shih M-J. , Venkatachalam TK , D'Cruz OJ , Chen C-L. , Uckun FM (1999). Synthesis of dual function (5R,6R)- and (5S,6S)-5-bromo-6-methoxy-5,6-dihydro-AZT-5'-(para-bromophenyl methoxyalaninyl phosphate) as novel spermicidal and anti-HIV agents. Antiviral Chem Chemother 10: 39—46.

31.

Lundberg BB (1997). A submicron lipid emulsion coated with amphipathic polyethylene glycol for parenteral administration of Paclitaxel (Taxol). J Pharm Pharmacol 49: 16—21.

32.

McCormack S. , Hayes R. , Lacey CJN , Johnson AM (2001). Microbicides in HIV prevention . BMJ 322: 410—413.

33.

Narotsky MG , Brownie CF , Kavlock RJ (1997). Critical period of carbon tetrachloride-induced pregnancy loss in Fischer-344 rats, with insights into the detection of resorption sites by ammonium sulfide staining. Teratology 56: 252—261.

34.

Nerurkar MM , Burton PS , Borchardt RT (1996). The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system. Pharm Res 13: 528— 534.

35.

Palmer AK (1968). Spontaneous malformations of the New Zealand White rabbit: the background to safety evaluation test. Lab Anim 2: 195— 206.

36.

Piomboni P. , Baccetti B. (2000). Spermatozoa as a vehicle for HIV-1 and other viruses. Mol Reprod Dev 56: 238—242.

37.

Quayle AJ , Xu C. , Mayer KH , Anderson DJ (1997). T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen . J Infect Dis 176: 960—968.

38.

Stadler J. , Kessedjian MJ , Perraud J. (1983). Use of the New Zealand white rabbit in teratology: incidence of spontaneous and drug-induced malformations. Food Chem Toxicol 21: 631—636.

39.

Sutherland IW (1998). Novel and established applications of microbial polysaccharides. Trends Biotechnol 16: 41—46.

40.

Tenjarla S. (1999). Microemulsions: an overview and pharmaceutical applications. Crit Rev Ther Drug Carrier Syst 16: 461—521.

41.

Turpin JA (2002). Considerations and development of topical microbicides to inhibit the sexual transmission of HIV. Expert Opin Investig Drugs 11: 1077—1097.

42.

Uckun FM , D'Cruz OJ (1999). Prophylactic contraceptives for HIV/AIDS. Hum Reprod Update 5: 506—514.

43.

United Nations Programme on HIV/AIDS (UNAIDS). Report on global HIV/AIDS epidemic: December 2001.

44.

Whitaker J. , Dix KM (1979). Double staining technique for rat foetus skeletons in teratological studies. Lab Anim 3: 309—310.

45.

Woodcock DM , Jefferson S. , Linsenmeyer ME , Crowther PJC , Chojnowski GMC , Williams B. , Bertoncello I. (1990). Reversal of multidrug resistance phenotype with Cremophor EL, a common vehicle for water-insoluble vitamins and drugs Cancer Res 5: 4199—4203.

46.

Zhang H. , Dornadula G. , Beumont M. , Livornese L Jr , Van Uitert B. , Henning K. , Pomerantz RJ (1998). Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 339: 1803—1809.